Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
neutral lipid, phosphatidylcholine, phosphatidylethanolamine drug combination
MeSH Supplementary Concept Data 2023
Details
Concepts
MeSH Supplementary
neutral lipid, phosphatidylcholine, phosphatidylethanolamine drug combination
Unique ID
C046637
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C046637
Entry Term(s)
AL 721
AL-721
neutral lipid - phosphatidylcholine - phosphatidylethanolamine
Registry Number
99751-63-0
CAS Type 1 Name
AL 721
Heading Mapped to
Drug Combinations
*Glycerides
*Phosphatidylcholines
*Phosphatidylethanolamines
Frequency
22
Note
extracts cholesterol from cellular membranes ; inhibits
HIV
infection of human peripheral blood lymphocytes or an immortalized helper T-cell line; contains neutral glycerides, phosphatidylcholine & phosphatidylethanolamine in 7:2:1 ratio
Source
N Engl J Med 1985;313(20):1289
Date of Entry
1985/11/05
Revision Date
2010/07/02
Expand All
Collapse All
neutral lipid, phosphatidylcholine, phosphatidylethanolamine drug combination
Preferred
Concept UI
M0135039
Registry Number
99751-63-0
Terms
neutral lipid, phosphatidylcholine, phosphatidylethanolamine drug combination
Preferred Term
Term UI
T773600
Date
07/02/2010
LexicalTag
NON
ThesaurusID
NLM (2010)
neutral lipid - phosphatidylcholine - phosphatidylethanolamine
Term UI
T773601
Date
07/02/2010
LexicalTag
NON
ThesaurusID
NLM (2010)
AL-721
Narrower
Concept UI
M0547841
Registry Number
0
Terms
AL-721
Preferred Term
Term UI
T165043
LexicalTag
LAB
ThesaurusID
NLM (1985)
AL 721
Term UI
T165044
LexicalTag
LAB
ThesaurusID
NLM (1985)
page delivered in 0.006s